T65.841
Toxic effect of xylazine, accidental (unintentional)
Clinical Classification Guidelines
Inclusion Terms
- Toxic effect of xylazine NOS
Medical Intelligence & Overview
Xylazine is a medication primarily used for veterinary purposes as a sedative and muscle relaxant. However, when humans are accidentally or unintentionally exposed to xylazine, it can cause a toxic effect. The ICD-10 code T65.841 specifically refers to cases where such toxic effects occur without intentional misuse, indicating accidental exposure. This condition requires prompt medical attention to manage symptoms and prevent serious health consequences.
Causes & Symptoms
Clinical Causes: Accidental exposure to xylazine intended for veterinary use. Use of xylazine in environments without proper safety measures. Misidentification or accidental ingestion of xylazine substances by humans. Improper handling or storage of veterinary medications containing xylazine.
Key Symptoms: Respiratory depression or difficulty breathing Low blood pressure (hypotension) Drowsiness or unconsciousness Bradycardia (slow heart rate) Hypothermia (low body temperature) Muscle weakness Nausea and vomiting Dizziness or lightheadedness Loss of coordination
Diagnostic & Treatment
Diagnosis Path: Diagnosis of xylazine toxicity involves a combination of patient history, clinical examination, and laboratory tests. Medical professionals will look for signs consistent with sedation and cardiovascular depression. Blood tests may detect xylazine levels, although this is rarely routine. It’s essential to rule out other causes of similar symptoms and to identify any contributing factors from the patient’s environment or exposure history.
Treatment Protocols: Ensuring a secure airway and providing oxygen support if respiratory depression occurs. Monitoring vital signs closely, with particular attention to heart rate, blood pressure, and breathing. Use of intravenous fluids to maintain blood pressure and hydration. Activated charcoal may be administered if ingestion was recent to limit absorption. Symptomatic treatment for specific issues, like vasopressors for severe low blood pressure. In some cases, medications that reverse sedation may be considered, but their use depends on clinical judgment. Continuous observation until symptoms resolve and toxicity diminishes.
Clinical Advice & FAQs
Billing Guidance
Is T65.841 a billable ICD-10 code?
Yes, T65.841 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T65.841?
Clinical documentation must specify the nature of Toxic effect of xylazine, accidental (unintentional) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference